GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS)
INR 2303.2
(-1.26%)
INR 2303.2
(-1.26%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 34.53 Billion | 32.51 Billion | 32.78 Billion | 31.98 Billion | 32.24 Billion | 31.28 Billion |
| Cost of Revenue | 21.71 Billion | 12.84 Billion | 14.49 Billion | 13.94 Billion | 13.97 Billion | 14.44 Billion |
| Gross Profit | 12.82 Billion | 19.66 Billion | 18.28 Billion | 18.04 Billion | 18.26 Billion | 16.83 Billion |
| Operating Expenses | 4.35 Billion | 12.28 Billion | 11.29 Billion | 11.53 Billion | 13.47 Billion | 11.27 Billion |
| Selling, General and Administrative Expenses | 2.28 Billion | 1.95 Billion | 2.26 Billion | 1.9 Billion | 2.18 Billion | 2.33 Billion |
| Research and Development Expenses | 25.43 Million | 19.09 Million | 18.28 Million | 18.07 Million | 21.8 Million | 23.26 Million |
| Other Expenses | - | 10.32 Billion | 9.03 Billion | 9.62 Billion | 11.29 Billion | 8.93 Billion |
| Cost and Expenses | 20.93 Billion | 25.13 Billion | 25.79 Billion | 25.47 Billion | 27.45 Billion | 25.71 Billion |
| Operating Income | 13.6 Billion | 8.39 Billion | 7.69 Billion | 7.61 Billion | 5.43 Billion | 6.53 Billion |
| Interest Expense | 17.98 Million | 18.1 Million | 19.96 Million | 35.31 Million | 63.35 Million | 5.54 Million |
| Income Tax Expense | 2.26 Billion | 2.28 Billion | 3.98 Billion | 1.92 Billion | 2.12 Billion | 2.37 Billion |
| Earnings before Tax | 8.16 Billion | 8.36 Billion | 7.79 Billion | 5.5 Billion | 3.05 Billion | 6.82 Billion |
| Net Income | 5.89 Billion | 6.1 Billion | 3.8 Billion | 3.58 Billion | 932.04 Million | 4.45 Billion |
| Earnings Per Share Basic | 34.83 | 36.05 | 22.48 | 21.14 | 5.50 | 26.29 |
| Earnings Per Share Diluted | 34.83 | 36.05 | 22.48 | 21.14 | 5.50 | 26.29 |
| Weighted Average Shares Outstanding | 169.4 Million | 169.4 Million | 169.4 Million | 169.4 Million | 169.4 Million | 169.4 Million |
| Weighted Average Shares Outstanding (Diluted) | 169.4 Million | 169.4 Million | 169.4 Million | 169.4 Million | 169.4 Million | 169.4 Million |
| Gross Margin | 0.37 | 0.60 | 0.56 | 0.56 | 0.57 | 0.54 |
| EBIT Margin | 0.26 | 0.28 | 0.26 | 0.26 | 0.19 | 0.22 |
| Profit Margin | 0.17 | 0.19 | 0.12 | 0.11 | 0.03 | 0.14 |
| EBITDA | 8.87 Billion | 9.03 Billion | 8.48 Billion | 5.35 Billion | 3.92 Billion | 7.31 Billion |
| Earnings Before Tax Margin | 0.39 | 0.26 | 0.23 | 0.24 | 0.17 | 0.21 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 10.1 Billion | 8.14 Billion | 9.29 Billion | 34.53 Billion | 8.05 Billion | 9.56 Billion |
| Cost of Revenue | 3.84 Billion | 4.62 Billion | 5.58 Billion | 21.71 Billion | 3.16 Billion | 3.54 Billion |
| Gross Profit | 6.26 Billion | 3.51 Billion | 3.71 Billion | 12.81 Billion | 4.88 Billion | 6.02 Billion |
| Operating Expenses | 3.21 Billion | 1.37 Billion | 1.32 Billion | 4.35 Billion | 2.87 Billion | 3.31 Billion |
| Selling, General and Administrative Expenses | 1.53 Billion | 1.37 Billion | 1.32 Billion | - | 1.29 Billion | 1.67 Billion |
| Research and Development Expenses | - | - | 25.43 Million | - | - | - |
| Other Expenses | 3.21 Billion | 356.4 Million | -876.82 Million | -483.84 Million | 281.1 Million | 282.1 Million |
| Cost and Expenses | 7.05 Billion | 6 Billion | 6.9 Billion | 26.07 Billion | 6.04 Billion | 6.85 Billion |
| Operating Income | 3.04 Billion | 2.14 Billion | 2.39 Billion | 8.45 Billion | 2.29 Billion | 2.99 Billion |
| Interest Expense | 2.7 Million | 3.7 Million | 7.68 Million | 17.98 Million | 3.2 Million | 4.3 Million |
| Income Tax Expense | 913.1 Million | 670.7 Million | 761.4 Million | 2.26 Billion | 197.1 Million | 816.5 Million |
| Earnings before Tax | 3.43 Billion | 2.49 Billion | 2.7 Billion | 8.16 Billion | 654.3 Million | 2.99 Billion |
| Net Income | 2.52 Billion | 1.82 Billion | 1.94 Billion | 5.89 Billion | 457.2 Million | 2.17 Billion |
| Earnings Per Share Basic | 14.91 | 10.76 | 11.48 | - | 2.70 | 12.84 |
| Earnings Per Share Diluted | 14.91 | 10.76 | 11.48 | - | 2.70 | 12.84 |
| Weighted Average Shares Outstanding | 169.34 Million | 169.4 Million | 169.4 Million | 169.4 Million | 169.4 Million | 169.4 Million |
| Weighted Average Shares Outstanding (Diluted) | 169.34 Million | 169.4 Million | 169.4 Million | 169.4 Million | 169.4 Million | 169.4 Million |
| Gross Margin | 0.62 | 0.43 | 0.40 | 0.37 | 0.61 | 0.63 |
| EBIT Margin | 0.36 | 0.28 | 0.28 | - | 0.31 | 0.33 |
| Profit Margin | 0.25 | 0.22 | 0.21 | 0.17 | 0.06 | 0.23 |
| EBITDA | 3.6 Billion | 2.3 Billion | 2.57 Billion | - | 2.46 Billion | 3.17 Billion |
| Earnings Before Tax Margin | 0.30 | 0.26 | 0.26 | 0.24 | 0.28 | 0.31 |
UREQF
3363
ATAZF
BRPT
ADVWW
TRITURBINE